Group 1 - The event "Investor Zero Distance" focused on the company Deyuan Pharmaceutical, part of the North Exchange 50 index, highlighting its innovative growth in the pharmaceutical industry [2][7] - Over 40 institutional representatives and investors participated in the event, engaging with company executives to understand the company's operations and market potential [2][6] - Deyuan Pharmaceutical specializes in the research, production, and sales of chronic disease treatment drugs, particularly in the endocrine therapy sector, and is expanding its product pipeline in related fields [4][6] Group 2 - The company's chairman and board secretary provided insights into the current business operations, strategic direction, and core technologies during face-to-face discussions with investors [6] - Industry experts discussed the North Exchange market, the North Exchange 50 index fund, and the long-term investment value of the A-share pharmaceutical sector during a subsequent seminar [6] - The event aimed to enhance communication between investors and listed companies, fostering a better understanding of company fundamentals and promoting rational investment culture [7]
投资者零距离——走进北证50成份股系列活动德源药业专场成功举办